RESEARCH

Overall research goal

Our research goal is to overcome global healthcare and biomedical challenges. Through interdisciplinary collaboration, we aim to develop cutting-edge tools and technologies that span from diagnosis to treatment.

We aim to leverage our expertise in mechanical engineering to deliver breakthrough advancements that address critical needs in the healthcare.

Micro physiological system (MPS)

We are developing a drug screening platform that uses a microfluidic system at a microscale to culture cells. This cell culture platform more precisely mimics physiological characteristics of human, and we believe our platform could eventually replace animal testing. Our main focus is to recapitulate the tumor microenvironment. There are hundreds anti-cancer drugs available, but determining which drug will be most effective is a challenging. By culturing patient tumor cells, we aim to create a drug screening platform that closely replicates the characteristics of the patient’s tumor and test the drugs using the screening platform.

Our goal is to use our technology to support in the treatment of cancer patients.

Diagnostic device

Our team is dedicated to developing innovative diagnostic systems for global health care challenges. One of our key projects was the CreDiT (CRISPR Enhanced Digital Testing) platform, designed for rapid and affordable nucleic acid testing. We’re particularly excited about its potential for screening a cervical cancer. CreDiT can detect HPVs on-site in less than 45 minutes, offering a sensitive and accurate solution.

We’re also passionate about developing portable diagnostic systems for early disease detection, including sepsis and kidney health monitoring. Using electrochemiluminescence (ECL) system, ECLipse, we are successfully developed an ultra-sensitive detection by separating signal generation and target detection.

Page updated

Google Sites

Report abuse